Title:
COLLAGENASE LIPOSOME INHALANT AND USE THEREOF IN TREATMENT OF PULMONARY FIBROSIS
Document Type and Number:
WIPO Patent Application WO/2024/041415
Kind Code:
A1
Abstract:
A collagenase liposome inhalant, used for treating pulmonary fibrosis after pulmonary inhalation. Use of a collagenase liposome in the preparation of an inhalant for treating pulmonary fibrosis, and a preparation method for the collagenase liposome inhalant. The collagenase liposome inhalant is selected from a nebulized inhalant and a powder inhalation. The collagenase liposome nebulized inhalant is nebulized into fine liquid droplets by means of a nebulizer and then orally inhaled into the lung for administration, and the collagenase liposome is concentrated on the lung to play a role. The collagenase liposome powder inhalation is actively inhaled into the lung by means of a dry powder inhaler.
Inventors:
JIN YIGUANG (CN)
ZHANG TONGTONG (CN)
ZHANG HUI (CN)
LIU YAN (CN)
YUAN BOCHUAN (CN)
DU LINA (CN)
ZHANG TONGTONG (CN)
ZHANG HUI (CN)
LIU YAN (CN)
YUAN BOCHUAN (CN)
DU LINA (CN)
Application Number:
PCT/CN2023/113045
Publication Date:
February 29, 2024
Filing Date:
August 15, 2023
Export Citation:
Assignee:
ACAD OF MILITARY MEDICAL SCIENCES (CN)
International Classes:
A61P35/00; A61K9/00; A61K31/58; A61K38/48
Domestic Patent References:
| WO2022074181A1 | 2022-04-14 | |||
| WO2007005672A2 | 2007-01-11 |
Foreign References:
| US20210059936A1 | 2021-03-04 | |||
| US20140227175A1 | 2014-08-14 | |||
| CN101081212A | 2007-12-05 | |||
| CN106975075A | 2017-07-25 | |||
| US20150071988A1 | 2015-03-12 | |||
| CN115414473A | 2022-12-02 |
Attorney, Agent or Firm:
BEIJING C & S LAW FIRM (CN)
Download PDF:
Previous Patent: WAREHOUSE MANAGEMENT SYSTEM AND SCHEDULING METHOD
Next Patent: SIGNAL TRANSMISSION METHOD AND APPARATUS, TERMINAL, AND STORAGE MEDIUM
Next Patent: SIGNAL TRANSMISSION METHOD AND APPARATUS, TERMINAL, AND STORAGE MEDIUM